The efficacy of platelet-rich plasma use as a treatment for the osteoarthritis
2016
Plaksina, J., Latvia Univ. of Agriculture, Jelgava (Latvia) | Ilgazs, A., Latvia Univ. of Agriculture, Jelgava (Latvia)
Platelet-rich plasma (PRP) is an autologous concentrated cocktail of growth factors and inflammatory mediators, and has been considered to be potentially effective for cartilage repair. Animal clinical studies suggest that PRP is a promising treatment for cartilage injuries and relieving symptoms due to its three biological properties: an anabolic effect, enhancement of cartilage regeneration and inhibition of inflammation. The aim of this article is to analyse the available evidence on the clinical application of this biological approach to animals for the injective treatment of cartilage lesions and joint degeneration, and also to support the rationale for the use of platelet concentrates and to give indications on what to expect from intra-articular injections of platelet-rich plasma (PRP) in animals. This article is a summary of analytical research papers about the use of platelet-rich plasma as a treatment for the osteoarthritis. The intra-articular injections do not just target cartilage; instead, platelet-rich plasma might influence the entire joint environment, leading to clinical improvement. Many biological variables might influence the clinical outcome and have to be studied to optimize PRP injective treatment of cartilage degeneration and osteoarthritis.
显示更多 [+] 显示较少 [-]